Posted inEndocrine Pharmacology Reproductive System
Linzagolix Pharmacology and Recent Advancements
Introduction Linzagolix, brand named Yselty®, is a selective, orally administered, non-peptide small molecule gonadotrophin-releasing hormone (GnRH) receptor antagonist developed by Kissei Pharmaceutical, aimed at treating uterine fibroids and endometriosis in…